GlaxoSmithKline settles healthcare fraud case for $3 billion

2012-07-022

Advertisement

résuméWASHINGTON GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S. history. The agreement, which still needs

Advertisement

WASHINGTON GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S. history.

The agreement, which still needs court approval, would resolve allegations that the British drugmaker broke U.S. laws in the marketing and development of pharmaceuticals.

GSK targeted the antidepressant Paxil to patients under age 18 when it was approved for adults only, and it pushed the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction, according to an investigation led by the U.S. Justice Department.

The company went to extreme lengths to promote the drugs, such as distributing a misleading medical journal article and providing doctors with meals and spa treatments that amounted to illegal kickbacks, prosecutors said.

In a third instance, GSK failed to give the U.S. Food and Drug Administration safety data about its diabetes drug Avandia, in violation of U.S. law, prosecutors said.

The misconduct continued for years beginning in the late 1990s and continued, in the case of Avandia's safety data, through 2007. GSK agreed to plead guilty to three misdemeanor criminal counts, one each related to the three drugs.

The agreement to settle the charges "is unprecedented in both size and scope," said James Cole, the No. 2 official at the U.S. Justice Department. He called the action "historic" and "a clear warning to any company that chooses to break the law."

The settlement includes $1 billion in criminal fines and $2 billion in civil fines.

GSK said in a statement it would pay the fines through existing cash resources. The company announced a $3 billion charge in November related to legal claims [ID:nL5E7M315A].

NEW 'ERA' AT GSK

Chief Executive Officer Andrew Witty said the misconduct originated "in a different era for the company" and will not be tolerated. "I want to express our regret and reiterate that we have learnt from the mistakes that were made," he said in a written statement.

The GSK settlement surpasses what had been the largest criminal case involving a drugmaker in U.S. history. In 2009, Pfizer Inc agreed to pay $2.3 billion to settle allegations it improperly marketed 13 drugs.

The cases follow a trend of U.S. authorities cracking down on how pharmaceuticals are sold, in part because of the rising cost of providing drugs through government programs.

Part of civil fines address allegations that, from 1994 to 2003, GSK underpaid money owed to Medicaid, the healthcare program for the poor run jointly by states and the federal government. The company had an obligation to tell the government its "best prices" but failed to do so, prosecutors said, and $300 million of the settlement will go to states and other public health authorities.

A portion of the $2 billion in civil fines may go to a group of whistleblowers who contributed to the government's investigation and who are eligible to share in the recovery under the False Claims Act. Cole said the amount has not been determined.

'INTEGRITY' PLAN

As part of the settlement, GlaxoSmithKline agreed to new restrictions by the U.S. government to prevent the use of kickbacks or other prohibited practices. The inspector general of the U.S. Department of Health and Human Services will oversee the "Corporate Integrity Agreement" for five years.

The company will not be able to compensate its salesmen based on sales goals for territories. It was also required to change its executive compensation program to allow the company to "claw back" certain pay for those engaged in misconduct.

Witty said GSK's U.S. unit has "fundamentally changed our procedures for compliance, marketing and selling. When necessary, we have removed employees who have engaged in misconduct."

Prosecutors have not brought criminal charges against any individuals in connection with the GSK case, although the settlement expressly leaves open that possibility. Cole declined to comment on the possibility of future charges.

Almost exactly a year ago GSK agreed to pay nearly $41 million to 37 states and the District of Columbia in an unrelated case about substandard manufacturing processes at a Puerto Rico factory.

In 2010, the company took a $2.4 billion charge in connection with Avandia to settle claims from patients.

GSK's shares were positive on the New York Stock Exchange on Monday, up 1.6 percent to $46.29 at 1400 EDT.

The case is U.S. v. GlaxoSmithKline LLC, U.S. District Court for the District of Massachusetts, No. 12-cr-10206.

WASHINGTON GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in U.S. history. The agreement, which still needs

MIAMI If Peter Budetti gets his way, the criminals who gorge on the U.S. healthcare system, bilking the government out of billions of dollars a year, will soon be on a much leaner diet. As Washington's point man on healthcare fraud, the 66-year-old B

LONDON Some 180 billion euros ($260 bln) is lost globally every year to fraud and error in healthcare -- enough to quadruple the World Health Organisation's and UNICEF's budgets and control malaria in Africa, experts said on Monday. A study by the Eu

WASHINGTON President Barack Obama's administration launched a new partnership with private insurance companies, state officials and other stakeholders to scale up efforts to tackle widespread and increasingly sophisticated healthcare fraud. Speaking

WASHINGTON U.S. Attorney General Eric Holder said on Tuesday the Department of Justice had charged 89 defendants in eight cities with healthcare fraud, and warned that budget cuts could limit future efforts to crack down on fraudulent claims. The gov

NEW YORK U.S. prosecutors have charged 49 current and former Russian diplomats and their family members with participating in a scheme to get health benefits intended for the poor by lying about their income. The charges come against a backdrop of te

LONDON GlaxoSmithKline Plc has agreed in principle to settle several long-standing disputes with the U.S. government over the way it marketed and developed drugs, at a cost of $3 billion, which is covered by existing provisions. Settlement of the civ

MIAMI The top two officials of a leading chain of community mental health centers were among four people arrested in Miami on Thursday in connection with a scheme involving about $200 million in fraudulent medical claims, U.S. prosecutors said. The f

HONG KONG Mobile technologies will be increasingly deployed to enable people in Asia to monitor and manage their health, with the market expected to hit $7 billion by 2017, an industry official said. In parts of Europe and the United States, diabetic

WASHINGTON A little over a year ago, Florida Attorney General Pam Bondi was on a mission. Along with a group of like-minded officials from other states, she was determined to be the first to test President Barack Obama's healthcare reform law at the

WASHINGTON Last month's Supreme Court ruling that upheld President Barack Obama's 2010 healthcare law could save the U.S. government some $84 billion over 11 years, the non-partisan Congressional Budget Office said on Tuesday. The savings would come

n">Pfizer Inc has agreed to pay $60.2 million to settle a U.S. government probe of the drugmaker's use of illegal payments to win business overseas, government officials said on Tuesday. The settlement is part of a broad crackdown on bribery by mu

BRUSSELS The European Union's top health official resigned on Tuesday after an anti-fraud investigation connected him to an attempt to influence EU tobacco legislation, the European Commission said. The EU's anti-fraud office OLAF found that a Maltes

SAN ANTONIO Women's health group Planned Parenthood has agreed to pay the state of Texas $1.4 million to settle allegations of fraud in billing to a health program for the poor, Texas Attorney General Greg Abbott said on Wednesday. But a spokeswoman

n">GlaxoSmithKline has agreed to pay $229 million to settle lawsuits brought by eight U.S. states related to improper marketing of its Avandia diabetes drug, the British drugmaker said on Wednesday. The company, in a regulatory filing, said the se

n">Within hours of the U.S. government's unprecedented release last week of a trove of Medicare billing data, a small fraternity of lawyers who specialize in representing whistleblowers in healthcare fraud cases began to mobilize. These lawyers ea

LONDON British drugmaker GlaxoSmithKline, which paid $3 billion last year to settle charges that it gave misleading information on its medicines, said on Tuesday it would publish more of its clinical research data. When the company agreed to the fine

TORONTO The Canadian province of Ontario said on Tuesday it has filed a lawsuit seeking C$50 billion ($45.9 billion) in damages from tobacco companies for healthcare costs incurred by taxpayers since 1955. In doing so, Ontario became the third of Can

WASHINGTON The U.S. government on Thursday charged 111 doctors, nurses and other defendants with Medicare crime schemes that exceeded $225 million in false billings, the largest health care fraud crackdown so far. Attorney General Eric Holder and Hea

WASHINGTON Healthcare programs are moving away from "pay and chase" and concentrating more on prevention in the battle against fraud that costs the government billions of dollars, U.S. officials told Congress on Wednesday. Overseers of Medicare

Updated

NEW YORK (Reuters Health) - Men who eat healthier diets may also have healthier sperm, new research from Spain shows. "A healthy, well-balanced diet is not just important for preventing diseases like diabetes, high cholesterol, or hypertension, but i